IN2014KN01319A - - Google Patents

Info

Publication number
IN2014KN01319A
IN2014KN01319A IN1319KON2014A IN2014KN01319A IN 2014KN01319 A IN2014KN01319 A IN 2014KN01319A IN 1319KON2014 A IN1319KON2014 A IN 1319KON2014A IN 2014KN01319 A IN2014KN01319 A IN 2014KN01319A
Authority
IN
India
Prior art keywords
formula
cinacalcet
pharmaceutically acceptable
acceptable salts
ethylamine
Prior art date
Application number
Other languages
English (en)
Inventor
Ruzena Vlasakova
Josef Hajicek
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of IN2014KN01319A publication Critical patent/IN2014KN01319A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
IN1319KON2014 2011-11-25 2012-11-21 IN2014KN01319A (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20110770A CZ2011770A3 (cs) 2011-11-25 2011-11-25 Zpusob výroby Cinacalcetu
PCT/CZ2012/000119 WO2013075679A1 (en) 2011-11-25 2012-11-21 A method of producing cinacalcet

Publications (1)

Publication Number Publication Date
IN2014KN01319A true IN2014KN01319A (cs) 2015-10-16

Family

ID=47435672

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1319KON2014 IN2014KN01319A (cs) 2011-11-25 2012-11-21

Country Status (7)

Country Link
CN (1) CN103958456B (cs)
BR (1) BR112014012434A2 (cs)
CZ (1) CZ2011770A3 (cs)
HU (1) HUP1400341A3 (cs)
IL (1) IL232678A (cs)
IN (1) IN2014KN01319A (cs)
WO (1) WO2013075679A1 (cs)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011068A (en) 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5504253A (en) 1994-07-15 1996-04-02 Nps Pharmaceuticals, Inc. Amine preparation
DE122005000033I2 (de) 1994-10-21 2006-11-23 Nps Pharma Inc Kalzium-Receptor aktive Verbindungen
ES2332016T3 (es) * 2005-05-16 2010-01-22 Teva Pharmaceutical Industries Ltd. Procedimiento para la preparacion de hidrocloruro de cinacalcet.
EP1975150A1 (en) * 2005-05-23 2008-10-01 Teva Pharmaceutical Industries Ltd. Cinacalcet salts
KR20080011320A (ko) * 2006-04-27 2008-02-01 테바 파마슈티컬 인더스트리즈 리미티드 시나칼셋 염기의 제조 방법
JP5027214B2 (ja) 2006-04-27 2012-09-19 テバ ファーマシューティカル インダストリーズ リミティド シナカルセット塩基の調製法
JP2009539823A (ja) 2006-06-08 2009-11-19 メディチェム エセ.ア. シナカルセットの調製のために有用な中間体化合物を調製するためのプロセス
JP5358566B2 (ja) * 2007-06-21 2013-12-04 アムジエン・インコーポレーテツド シナカルセトおよびその塩を合成する方法
ES2401851T3 (es) * 2008-10-28 2013-04-25 Zach System S.P.A. Proceso para preparación de Cinacalcet

Also Published As

Publication number Publication date
CN103958456B (zh) 2015-10-21
CZ303627B6 (cs) 2013-01-16
HUP1400341A3 (en) 2014-12-29
BR112014012434A2 (pt) 2017-06-06
CZ2011770A3 (cs) 2013-01-16
HUP1400341A2 (en) 2014-10-28
IL232678A0 (en) 2014-08-03
WO2013075679A1 (en) 2013-05-30
CN103958456A (zh) 2014-07-30
IL232678A (en) 2017-05-29

Similar Documents

Publication Publication Date Title
BR112014007674A2 (pt) método para produzir derivados de 4,4-diflúor-3,4-dihidroisoquinolina
UY33317A (es) Nuevos derivados de pirazol
TN2013000347A1 (en) Production method of optically active dihydrobenzofuran derivative
SG10201804021TA (en) Methods of preparing inhibitors of influenza viruses replication
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
MX359825B (es) Compuesto pirazol y su uso farmaceutico.
BRPI1006534A2 (pt) sal do composto 1, processo para preparar um sal do composto 1, e processo para preparar um sal misto do composto 1
BR112014001769A2 (pt) processo para a preparação de 1,4-ciclo-hexanodimetanol
FR2975990B1 (fr) Procede de preparation d'un compose organique fluore
ZA201305059B (en) Organic amine salts of azilsartan,preparation method and use thereof
MX2012001722A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
IN2014KN01319A (cs)
UA111329C2 (uk) Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою
ES2556470T3 (es) Procedimiento para preparar [3-[(6-cloro-3-piridinil)metil]-2-tiazolidiniliden]cianamida
UA117900C2 (uk) Спосіб синтезу 3-(2-бром-4,5-диметоксифеніл)пропаннітрилу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою
JO3189B1 (ar) طريقة جديدة لتخليق (e2) -3- (3, 4- داي ميثوكسي فينيل)بروب-2 - يننيتريل واستخدامها لتخليق ايفابرادين والاملاح المضافة منها مع حمض مقبول صيدلانيا
JO3276B1 (ar) طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا.
EP2692721A4 (en) DIAMOND COMPOUND WITH A SULFURIC ACID GROUP AND METHOD OF MANUFACTURING THEREOF
BR112013015903A2 (pt) polimorfo cristalino, processo para preparar um polimorfo, composição farmacêutica, forma purificada do polimorfo, uso de um polimorfo, processo para preparar um composto, e, composto.
MX2013002656A (es) Nuevo proceso.
UA111156C2 (uk) Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою
MX2013011705A (es) Nuevo procedimiento de sintesis del 3-(2-bromo-4,5-dimetoxifenil)p ropanonitrilo, y aplicacion a la sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
BR112013020015A2 (pt) (5s,8s)-3-(4'-cloro-3'-flúor-4-metilbifenil-3-il)-4-hidróxi-8-metóxi-1-azaspiro[4.5]dec-3-en-2-ona (composto a) para terapia
GEP20156369B (en) New process for synthesis of ivabradine and addition salts therewith pharmaceutically acceptable acid
MX2014003770A (es) Tetrahidrato de la sal de l-arginina del acido s-(-)-9-fluoro-6,7-dihidro-8-(4-hidroxipiperidin-1-il)-5-metil-1- oxo-1h,5h-benzo[i,j] quinolizin-2-carboxilico puro, y un proceso para su preparacion.